Novanta (NOVT) stock price, chart and financials
Price chart
Financials
- Revenue (quarter)
- $265.8M
- Gross margin
- 44.54%
- Net income (quarter)
- $12.5M
- Net margin
- 6.00%
- Return on equity
- 5.11%
- Book value per share
- $42.75
- Price to book
- 3.28
- Debt to assets
- 24.45%
Company profile
Novanta Inc supplies core technology solutions to medical, life science, and advanced industrial OEMs, leveraging proprietary expertise in precision medicine, precision manufacturing, robotics and automation, and advanced surgery. It has two segments: Automation Enabling Technologies and Medical Solutions. Automation Enabling Technologies, which generates the majority of revenue, provides laser beam steering and scanning solutions, laser sources, and robotic and precision motion technologies. The Medical Solutions segment provides medical-grade technologies, including medical insufflators, endoscopic pumps, and integrated operating room technologies. The company operates in the United States, Germany, and other markets, with revenue generated from the United States.
Frequently asked questions
Is Novanta (NOVT) profitable?
Yes. Novanta earned $61.8M in net income over the trailing twelve months, a net margin of 6.00%.
How much revenue does Novanta (NOVT) make?
Novanta generated $1.0B in revenue over the trailing twelve months, up 10.27% year over year.
What is NOVT's P/E ratio?
Novanta trades at 85.8 times trailing twelve-month earnings, on an EPS of $1.59.
How do I buy stock in Novanta (NOVT)?
NOVT trades commission-free with a Light Horse Securities brokerage account — from the mobile app, the web at Light Horse Dashboard, the trading API, or an AI agent connected over MCP. The trade panel on this page places the order once you are signed in.
Quotes and charts are not real-time and must not be relied on for trade decisions or valuation.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.